WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock

$2.16-0.12 (-5.26%)
Updated Jul 12, 2024
AMLX Price
$2.16
Fair Value Price
N/A
Market Cap
$146.89M
52 Week Low
$1.58
52 Week High
$25.48
P/E
-2.08x
P/B
0.45x
P/S
0.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$398.00M
Earnings
-$71.10M
Gross Margin
65.7%
Operating Margin
-16.5%
Profit Margin
-17.9%
Debt to Equity
0.29
Operating Cash Flow
$17M
Beta
1.18
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AMLX Overview

Amylyx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, for the treatment of ALS. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, MA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AMLX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AMLX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
AMLX is good value based on its book value relative to its share price (0.45x), compared to the US Biotechnology industry average (6.45x)
P/B vs Industry Valuation
AMLX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more AMLX due diligence checks available for Premium users.

Be the first to know about important AMLX news, forecast changes, insider trades & much more!

AMLX News

Valuation

AMLX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.08x
Industry
-12.81x
Market
32.2x

AMLX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.45x
Industry
6.45x
AMLX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AMLX's financial health

Profit margin

Revenue
$88.6M
Net Income
-$118.8M
Profit Margin
-134%
AMLX's Earnings (EBIT) of -$65.66M... subscribe to Premium to read more.
Interest Coverage Financials
AMLX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$417.5M
Liabilities
$93.0M
Debt to equity
0.29
AMLX's short-term assets ($410.53M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AMLX's short-term assets ($410.53M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AMLX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$489.0k
Investing
$819.0k
Financing
$131.0k
AMLX's operating cash flow ($16.50M)... subscribe to Premium to read more.
Debt Coverage Financials

AMLX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AMLX$146.89M-5.26%-2.08x0.45x
RPTX$147.71M-1.97%-3.19x0.64x
CMPX$148.60M+3.85%-3.09x0.95x
PDSB$150.02M+5.41%-2.99x4.03x
CLLS$150.08M+4.50%-1.88x1.66x

Amylyx Pharmaceuticals Stock FAQ

What is Amylyx Pharmaceuticals's quote symbol?

(NASDAQ: AMLX) Amylyx Pharmaceuticals trades on the NASDAQ under the ticker symbol AMLX. Amylyx Pharmaceuticals stock quotes can also be displayed as NASDAQ: AMLX.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.

What is the 52 week high and low for Amylyx Pharmaceuticals (NASDAQ: AMLX)?

(NASDAQ: AMLX) Amylyx Pharmaceuticals's 52-week high was $25.48, and its 52-week low was $1.58. It is currently -91.52% from its 52-week high and 37.14% from its 52-week low.

How much is Amylyx Pharmaceuticals stock worth today?

(NASDAQ: AMLX) Amylyx Pharmaceuticals currently has 68,005,749 outstanding shares. With Amylyx Pharmaceuticals stock trading at $2.16 per share, the total value of Amylyx Pharmaceuticals stock (market capitalization) is $146.89M.

Amylyx Pharmaceuticals stock was originally listed at a price of $18.07 in Jan 7, 2022. If you had invested in Amylyx Pharmaceuticals stock at $18.07, your return over the last 2 years would have been -88.05%, for an annualized return of -65.43% (not including any dividends or dividend reinvestments).

How much is Amylyx Pharmaceuticals's stock price per share?

(NASDAQ: AMLX) Amylyx Pharmaceuticals stock price per share is $2.16 today (as of Jul 12, 2024).

What is Amylyx Pharmaceuticals's Market Cap?

(NASDAQ: AMLX) Amylyx Pharmaceuticals's market cap is $146.89M, as of Jul 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Amylyx Pharmaceuticals's market cap is calculated by multiplying AMLX's current stock price of $2.16 by AMLX's total outstanding shares of 68,005,749.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.